Today's Low
₹ 273.60
Today's High
₹ 279.70
52 Weeks Low
₹ 295.10
52 Weeks High
₹ 1,234.40
Lower
₹ 221.00
Upper
₹ 331.50
Nureca Limited, a B2C company, engages in the home healthcare and wellness products business in India. It offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeter, glucose meter, and thermometer; orthopedic products, including massagers, pain monitors, posture correctors, and rehabilitation products; and humidifiers and steamers, personal scales, yoga and exercise, fitness tracking, and dental and personal care products. The company also provides mother and baby care products comprising baby feeding, carry cots, baby skincare, and bottle warmers and steamers; nutritional supplements and weight management products; and ECG, fitness tracker, and smart weighing scale products. Nureca Limited offers its products under Dr Trust, Dr Physio, and Trumom brands. The company sells its products through third party e-commerce players, distributors, and retailers; and through its website, drtrust.in. Nureca Limited was incorporated in 2016 and is based in Chandigarh, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
---|---|---|---|---|---|---|
Total Current Assets | 186.6 | 239.2 | 186.2 | 32.8 | 23.0 | 7.0 |
Total Non-Current Assets | 17.3 | 12.8 | 4.1 | 1.1 | 0.6 | 0.0 |
Total Assets | 203.9 | 252.1 | 190.3 | 33.9 | 23.5 | 7.0 |
Total Current Liabilities | 8.9 | 45.3 | 24.0 | 9.5 | 15.3 | 5.3 |
Total Non-Current Liabilities | 0.1 | 3.6 | 3.2 | 9.4 | 0.3 | 0.0 |
Shareholder's Funds | 194.9 | 203.2 | 163.1 | 14.9 | 8.0 | 1.7 |
Total Liabilities | 203.9 | 252.1 | 190.3 | 33.9 | 23.5 | 7.0 |
The Industry Quick Ratio stands at 2.22, vs the Quick Ratio of 1.72, which results in a Negative aspect.
The Industry Price to BV stands at 10.54, vs the Price to BV of 1.40, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.21, vs the Debt to Equity Ratio of 0.70, which results in a Negative aspect.
The Industry Current Ratio stands at 2.86, vs the Current Ratio of 3.45, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
---|---|---|---|---|---|---|
Total Income | 111.3 | 255.6 | 213.5 | 99.4 | 61.9 | 20.1 |
Total Expenditure | 126.3 | 200.0 | 151.9 | 89.7 | 52.8 | 15.7 |
Operating Profit(Excl OI) | -7.9 | 63.2 | 64.4 | 9.8 | 9.1 | 4.4 |
Add: Other Income | 7.1 | 7.7 | 2.8 | 0.1 | 0.1 | 0.0 |
Operating Profit | -7.9 | 63.2 | 64.4 | 9.8 | 9.1 | 4.4 |
Less: Interest | 0.5 | 0.7 | 1.6 | 0.8 | 0.2 | 0.1 |
PBDT | -8.4 | 62.5 | 62.8 | 9.0 | 8.9 | 4.3 |
Less: Depreciation Amortization | 2.4 | 1.5 | 0.4 | 0.4 | 0.1 | 0.0 |
PBT & Exceptional Items | -10.7 | 61.0 | 62.3 | 8.6 | 8.8 | 4.3 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | -10.7 | 61.0 | 62.3 | 8.6 | 8.8 | 4.3 |
Less: Taxation | -2.5 | 16.0 | 16.0 | 2.2 | 2.6 | 1.2 |
Profit After Tax | -8.3 | 45.0 | 46.4 | 6.4 | 6.2 | 3.1 |
Earnings Per Share | -0.8 | 4.5 | 4.6 | 91.4 | 88.9 | 44.5 |
The Industry PAT Growth stands at 31.38, vs the PAT Growth of 2.71, which results in a Negative aspect.
The Industry PE Ratio stands at 65.35, vs the PE Ratio of 336.50, which results in a Positive aspect.
The Industry PAT Margin stands at 15.60, vs the PAT Margin of 6.43, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.19, vs the Dividend Yield of 0.00, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
---|---|---|---|---|---|---|
Profit Before Tax | -10.7 | 61.0 | 62.3 | 8.6 | 8.8 | 4.3 |
Tax Paid | -4.1 | -18.0 | -15.1 | 0.0 | 0.0 | 0.0 |
Adjustment | -3.5 | -3.7 | 0.1 | 1.2 | 0.3 | 0.0 |
Changes In Working Capital | -10.7 | 61.0 | 62.3 | 8.6 | 8.8 | 4.3 |
Cash Flow after changes in Working Capital | 14.4 | 19.4 | 49.9 | -7.9 | 0.3 | 0.1 |
Cash Flow from Operating Activities | 10.2 | 1.4 | 34.9 | -7.9 | 0.3 | 0.1 |
Cash Flow from Investing Activities | -16.5 | -3.1 | -110.0 | -0.4 | -0.1 | 0.0 |
Cash Flow from Financing Activities | -1.5 | -7.3 | 92.3 | 8.3 | -0.1 | -0.1 |
Net Cash Inflow / Outflow | -7.7 | -9.0 | 17.2 | 0.0 | 0.0 | 0.0 |
Opening Cash & Cash Equivalents | 8.2 | 17.2 | 0.1 | 0.1 | 0.1 | 0.0 |
Closing Cash & Cash Equivalent | 0.5 | 8.2 | 17.2 | 0.1 | 0.1 | 0.1 |
The Industry PFCF Ratio stands at -61.68, vs the PFCF Ratio of 0.00, which results in a Positive aspect.
The Industry PCF RATIO stands at 54.65, vs the PCF RATIO of 0.00, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 223.7 | 313.5 | 212.3 | 212.3 | 277.9 | 367.8 | 255.3 | 410.5 | 480.8 | 469.4 | 1,194.8 | 318.4 |
Total Income | 282.8 | 345.5 | 239.0 | 233.7 | 296.8 | 386.7 | 267.0 | 427.6 | 498.1 | 490.5 | 1,216.2 | 331.2 |
Total Expenditure | 266.3 | 299.7 | 241.3 | 246.8 | 287.0 | 416.9 | 312.6 | 437.9 | 429.6 | 409.1 | 723.9 | 274.7 |
PBIDT (Excl OI) | -42.6 | 13.9 | -29.0 | -34.6 | -9.2 | -49.1 | -57.3 | -27.4 | 51.2 | 60.3 | 470.9 | 43.7 |
Other Income | 59.0 | 32.0 | 26.7 | 21.5 | 19.0 | 18.9 | 11.7 | 17.1 | 17.4 | 21.1 | 21.4 | 12.8 |
Operating Profit | 16.5 | 45.8 | -2.3 | -13.1 | 9.8 | -30.2 | -45.6 | -10.3 | 68.6 | 81.4 | 492.3 | 56.5 |
Interest | 1.1 | 0.8 | 1.2 | 1.0 | 1.1 | 1.0 | 1.4 | 2.9 | 1.1 | 1.2 | 2.2 | 3.8 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 15.4 | 45.0 | -3.5 | -14.1 | 8.7 | -31.2 | -46.9 | -13.1 | 67.4 | 80.2 | 490.1 | 52.7 |
Depreciation | 5.9 | 5.9 | 5.8 | 5.6 | 6.0 | 6.2 | 6.1 | 5.9 | 4.2 | 3.1 | 1.6 | 0.7 |
Profit Before Tax | 9.5 | 39.1 | -9.3 | -19.7 | 2.7 | -37.4 | -53.0 | -19.1 | 63.2 | 77.1 | 488.6 | 52.0 |
Tax | 7.8 | 10.2 | -2.2 | -4.4 | -0.3 | -8.5 | -11.7 | -5.0 | 15.9 | 22.7 | 126.6 | 13.1 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 1.7 | 28.9 | -7.1 | -15.3 | 3.0 | -28.9 | -41.3 | -14.0 | 47.3 | 54.3 | 362.0 | 38.9 |
Net Profit | 1.7 | 28.9 | -7.1 | -15.3 | 3.0 | -28.9 | -41.3 | -14.0 | 47.3 | 54.3 | 362.0 | 38.9 |
ADDITIONAL INFOS: | ||||||||||||
Equity Capital | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 0.2 | 2.9 | -0.7 | -1.5 | 0.3 | -2.9 | -4.1 | -1.4 | 4.7 | 5.4 | 36.2 | 4.6 |
Operating Profit Margin | 7.4 | 14.6 | -1.1 | -6.2 | 3.5 | -8.2 | -17.9 | -2.5 | 14.3 | 17.3 | 41.2 | 17.7 |
Net Profit Margin | 0.7 | 9.2 | -3.3 | -7.2 | 1.1 | -7.9 | -16.2 | -3.4 | 9.8 | 11.6 | 30.3 | 12.2 |
The Industry Mcap Growth stands at 74.40, vs the Mcap Growth of 0.00, which results in a Negative aspect.
The Industry Net Sales Growth stands at 16.62, vs the Net Sales Growth of 60.63, which results in a Positive aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 288.45 | 294.75 | 279.61 |
R3 | 285.53 | 285.40 | 277.93 |
R2 | 282.62 | 282.55 | 277.37 |
R1 | 279.43 | 279.30 | 276.81 |
Pivot | 276.52 | 276.45 | 276.52 |
S1 | 273.33 | 273.20 | 275.69 |
S2 | 270.42 | 270.35 | 275.13 |
S3 | 267.23 | 267.10 | 274.57 |
S4 | 264.05 | 258.15 | 272.90 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
72.90
Neutral
RSI
33.21
Neutral
ROC
-3.49
Bearish
UltimateOscillator
32.36
Neutral
Williams Indicator
-50.44
Neutral
CCI Indicator
-82.61
Neutral
MACD
-2,702.47
Bearish
Stochastic Indicator
49.60
Neutral
ATR
12.61
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
24-02-2022 | 3.00 | 30 | Interim |
21-09-2021 | 2.00 | 20 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
07-02-2024 | Quarterly Results |
04-11-2023 | Quarterly Results |
10-08-2023 | Quarterly Results |
23-05-2023 | Audited Results & A.G.M. |
03-02-2023 | Quarterly Results |
11-11-2022 | Quarterly Results |
12-08-2022 | Quarterly Results |
28-05-2022 | Audited Results & A.G.M. |
12-02-2022 | Quarterly Results & Interim Dividend |
10-11-2021 | Quarterly Results |
31-07-2021 | Quarterly Results |
16-06-2021 | Final Dividend & Audited Results |